Burlington Stores & Its Customers Raise Nearly $4 Million for LLS in the Fight Against Blood Cancer

The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering amazing deals to customers every time they shop, teamed up for the 19th consecutive year to raise critical funds to support LLS’s goal of creating a world without blood cancer, and to furthering their LLS Children’s Initiative, a $100 million multi-year endeavor to help children not only survive, but thrive after treatment. This past fall, Burlington customers donated $1 or more at checkout in the retailers more than 750 stores nationwide, which resulted in nearly $4 million of support.

The newly established LLS Children’s Initiative is dedicated to changing the course of treatment and care, while providing much-needed financial and emotional support to the children and their families impacted by blood cancer. The LLS Children’s Initiative includes: new research grants to advance novel therapies and the first global precision medicine clinical trial for pediatric acute leukemia called LLS PedAL; enhanced free education and support services for children and their families; and renewed policy and advocacy efforts.

In addition to this year’s in-store fundraising campaign, Burlington hosted several celebratory outdoor parades in front of select store locations nationwide for young cancer survivors. These events allowed store associates to recognize and cheer for local young cancer survivors and their families, while keeping safe and socially distant. Each young hero received a Burlington gift card, as well as a personalized gift bag from Burlington based on their interests and personal style. Events occurred in the following communities across the country: New York City, Los Angeles, Miami, Chicago, Philadelphia, Houston, Dallas, Washington, D.C., Boston and Atlanta.

“LLS is proud to partner with our Honored Friend and #1 National Corporate Retail Partner, Burlington Stores, and grateful for their tremendous support and their customers’ readiness to give,” said Louis J. DeGennaro, Ph.D., LLS president and chief executive officer. “For close to two decades now, Burlington’s commitment has helped LLS invest more than $1.3 billion in cutting edge research worldwide, fueling nearly every critical advancement in blood cancer treatment. As the leading source of free blood cancer information, education and support, we can reach blood cancer patients who need our support and services now, more than ever.”